Costco's refusal to stock mifepristone, the abortion pill, empowers anti-abortion activists. The company cites low member demand, a decision criticized by abortion rights advocates as hindering access to safe and effective medication abortion. This move follows pressure campaigns from conservative groups and raises concerns about healthcare access
Costco will not stock mifepristone, citing low member and patient demand for the abortion pill. This decision, first reported by Bloomberg, follows pressure from conservative activist groups and comes despite the medication's proven safety and effectiveness in medication abortion
Costco's refusal to stock mifepristone, the abortion pill, is hailed as a victory by anti-abortion activists. Following a lobbying campaign, the retailer cited low member demand, a claim disputed by abortion rights advocates who highlight the drug's safety and efficacy. This decision fuels concerns about access to medication abortion and signals further pressure on pharmacies nationwide
Costco's refusal to stock mifepristone, the abortion pill, follows pressure from anti-abortion groups. Alliance Defending Freedom legal counsel Michael Ross stated that retailers like Costco prioritize long-term customer relationships and see dispensing abortion medication as a significant risk, outweighing any potential benefit. This decision, lauded by conservative activists, raises concerns about access to medication abortion
Costco's refusal to stock mifepristone, the abortion pill, reflects a growing trend among pharmacies prioritizing patient health and safety concerns raised by anti-abortion advocates. These groups argue that dispensing abortion medication contradicts the core mission of retail pharmacies and poses potential risks to women's well-being
Mifepristone, the abortion pill, is safe and effective, with medication abortion comprising nearly two-thirds of US pregnancy terminations—a 10% increase since 2020. Despite this, and its proven safety even via telehealth, anti-abortion groups continue to spread misinformation. The rising popularity of medication abortion highlights the critical need for increased access to this essential healthcare
Costco's refusal to stock mifepristone, the abortion pill, alarms Hey Jane CEO Kiki Freedmand. Freedmand highlights mifepristone's safety and calls Costco's decision a setback for accessible, legal abortion care
Expanding mifepristone access is crucial for protecting reproductive healthcare. Each pharmacy dispensing this medication improves access to safe, legal, and essential abortion care within communities, breaking down barriers for patients
Mifepristone's safety profile surpasses that of both penicillin and Viagra, highlighting its established safety record
Costco's refusal to stock mifepristone, the abortion pill, draws sharp criticism from Senator Tammy Duckworth, who calls it a "deeply disappointing capitulation to the far right's intimidation." This decision, following pressure from conservative activist groups, raises concerns about access to medication abortion and the influence of political pressure on healthcare providers
Expanding mifepristone access is crucial for protecting reproductive healthcare. Increased availability of this abortion pill ensures patients receive safe, legal, and essential care
Senator Duckworth decried the Republican Party's anti-choice stance, warning of shrinking reproductive rights for American women. She joined fellow Democrats in urging Costco to ignore conservative pressure and provide mifepristone, the abortion pill, highlighting the crucial need for expanded access to reproductive healthcare
Costco's decision to not stock mifepristone followed pressure from anti-abortion groups, including a letter spearheaded by the Alliance Defending Freedom (ADF). This letter, signed by financial institutions like Inspire Investing, leveraged their collective $56 million Costco stock ownership to urge the retailer against carrying the abortion pill
Costco's decision to not dispense mifepristone, the abortion pill, follows pressure from anti-abortion groups who warned of significant legal, political, and reputational risks. The retailer cited low member demand, but critics argue this limits access to safe and effective medication abortion
Costco's decision to not dispense mifepristone reflects pressure from anti-abortion groups who argue that providing abortion services negatively impacts profitability by alienating potential customers with large families. These groups contend that focusing on family-oriented products and services is key to Costco's long-term financial success
For two decades, HuffPost has been fearless, unflinching, and relentless in pursuit of the truth. Support our mission to keep us around for the next 20 — we can’t do this without you.
We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.
Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. We hope you will join us once again.
We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.
Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. We hope you will join us once again.
Already contributed? Log in to hide these messages.
Inspire Investing was also behind a petition last year that collected signatures from more than 6,000 Costco members opposed to the store carrying the abortion pill.
Ross told Bloomberg that ADF will now shift its focus to getting mifepristone out of Walgreens and CVS, which both announced last year they were dispensing the medication at their pharmacies in most states where abortion remains legal. Both have a much larger pharmacy footprint than Costco.
Walgreens already bowed to pressure from attorneys general in several red states and agreed not to dispense mifepristone in Alaska, Iowa, Kansas and Montana, even though distribution remains legal there.
Source: Original Article